Breast cancer: Partial breast irradiation after breast conserving surgery;Brustkrebs: Teilbrustbestrahlung nach brusterhaltender Operation

Deutsches Arzteblatt

Volumn 103, Issue 9, 2006, Pages

  Sauer, Rolf ^a   Wenz, Frederik ^b   Haase, Wulf ^c   Souchon, Rainer ^d   Sautter Bihl, Marie Luise ^e  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c St Vincentius Kliniken gAG   (Germany)

^d Allgemeines Krankenhaus Hagen gem GmbH   (Germany)

^e STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

Brachytherapy; Breast cancer; Breast conserving surgery; Cancer therapy; Irradiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE;

ARTICLE; BALLOON CATHETER; BRACHYTHERAPY; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMPUTER ASSISTED RADIOTHERAPY; ELECTRON BEAM; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GERIATRIC PATIENT; GOLD STANDARD; HUMAN; IMPLANT; INTERMETHOD COMPARISON; INTRAOPERATIVE RADIOTHERAPY; LINEAR ACCELERATOR; PATIENT SELECTION; POSTOPERATIVE CARE; PROGNOSIS; PUBLISHING; RADIATION INJURY; ROENTGEN APPARATUS; THERAPY EFFECT;

EID: 34247550851     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kreienberg R, Kopp I, Lorenz W et al.: Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der beteiligten medizinisch-wissenschaftlichen Fachgesellschaften "Diagnostik, Therapie und Nachsorge des Mammakarzinoms der Frau. AWMF-Register Nr. 032/045 www.awmf-online, www.leitlinien.net
2. Tiefenbacher U, Scheda A, Melchert F et al.: Radiotherapie bei brusterhaltender Operation. Onkologe 2003; 9: 1023-33.
3. Fisher B, Bryant J, Dignam JJ et al.: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20: 4141-9.
4. Fyles AW, McCready DR, Manchul LA et al.: Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004; 351: 963-70.
5. Winzer KJ, Sauer R, Sauerbrei W et al.: Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 2004; 40: 998-1005.
6. Bartelink H, Horiot JC, Poortmans P et al.: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345: 1378-87.
7. Fisher B, Anderson S, Bryant J et al.: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41.
8. Veronesi U, Cascinelli N, Mariani L et al.: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-32.
9. Silverstein MJ: The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003; 186: 337-43.
10. Ott OJ, Potter R, Hammer J et al.: Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol 2004; 180: 642-9.
11. Polgar C, Fodor J, Nemeth G et al.: HDR brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: Six-year results of a comparative study using matched controls. Radiother Oncol 2003; 66: 14.
12. Strnad V, Ott O, Potter R et al.: Interstitial brachytherapy alone after breast conserving surgery: Interim results of a German-Austrian multicenter phase II trial. Brachytherapy 2004; 3: 115-9.
13. Vicini F, Arthur D, Polgar C, Kuske R: Defining the efficacy of accelerated partial breast irradiation: The importance of proper patient selection, optimal quality assurance, and common sense. Int J Radiat Oncol Biol Phys 2003; 57: 1210-3.
14. Baglan KL, Sharpe MB, Jaffray D et al.: Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003; 55: 302-11.
15. Vicini FA, Remouchamps V, Wallace M et al.: Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003; 57: 1247-53.
16. Dobelbower RR, Merrick HW, Eltaki A, Bronn DG: Intra-operative electron beam therapy and external photon beam therapy with lumpectomy as primary treatment for early breast cancer. Ann Radiol (Paris) 1989; 32: 497-501.
17. Gatzemeier W, Orecchia R, Gatti G, Intra M, Veronesi U: (Intraoperative radiotherapy (IORT) in treatment of breast carcinoma - a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand. Strahlenther Onkol 2001; 177: 330-7.
18. Veronesi U, Gatti G, Luini A et al.: Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 2003; 138: 1253-6.
19. Kraus-Tiefenbacher U, Steil V, Bauer L, Melchert F, Wenz F: A novel mobile device for intraoperative radiotherapy (IORT). Onkologie 2003; 26: 596-8.
20. Vaidya JS, Baum M, Tobias JS et al.: Targeted intra-operative radiotherapy (Targit): An innovative method of treatment for early breast cancer. Ann Oncol 2001; 12: 1075-80.
21. Herskind C, Steil V, Kraus-Tiefenbacher U, Wenz F: Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X rays for early-stage breast cancer. Radiat Res 2005; 163: 208-15.
22. Rosenstein BS, Lymberis SC, Formenti SC: Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys 2004; 60: 1393-404.
23. Bentzen SM, Thames HD, Overgaard M: Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol 1989; 15: 267-74.